Premium
The impact of dysglycaemia on bone mineral accrual in young people with cystic fibrosis
Author(s) -
Rana Malay,
Munns Craig F.,
Selvadurai Hiran,
Briody Julie,
Craig Maria E.
Publication year - 2013
Publication title -
clinical endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.055
H-Index - 147
eISSN - 1365-2265
pISSN - 0300-0664
DOI - 10.1111/j.1365-2265.2012.04484.x
Subject(s) - medicine , bone mineral , impaired glucose tolerance , endocrinology , femoral neck , diabetes mellitus , bone density , gastroenterology , osteoporosis , type 2 diabetes
Summary Objective The effect of dysglycaemia on bone mineral density ( BMD ) has not been studied in young people with CF . We examined factors associated with BMD in a tertiary paediatric CF clinic. Design Retrospective, clinic‐based study at The C hildren's H ospital at W estmead, S ydney. Patients Young people with CF aged ≤18 years. Measurements Bone mineral density was measured by dual‐energy X ‐ray absorptiometry; main outcome measures were total body ( TB ), lumbar spine ( LS ) and femoral neck ( FN ) BMD and bone mineral content ( BMC ), and LS volumetric BMD (v BMD ), reported as z scores for height. Dysglycaemia, based on oral glucose tolerance test, was defined as CF ‐related diabetes ( CFRD ) or impaired glucose tolerance ( IGT ). Results Overall, 14 of 81 (17%) had CFRD , 6 (7%) IGT and 61 (76%) normal glucose tolerance ( NGT ). Mean age was 14·9 ± 2·4 years and mean height z score −0·68 ± 1·39. Osteopenic ( z score ≤−2) TB , LS or FN BMD was present in 30 of 81 (37%), BMC in 42 (52%) and v BMD in 10 (5%). Across the three groups, there were differences in LS v BMD ( CFRD , −0·67 ± 0·76; IGT , −0·52 ± 0·76; NGT , −0·05 ± 1·39; P = 0·04), LS BMD ( P < 0·01), LS BMC ( P = 0·01) and TB BMD ( P = 0·01). In multivariate linear regression, LS BMC was associated with dysglycaemia (β = 0·56; 95% CI , 0·00–1·13; P = 0·05) and approached significance for FEV 1 (β = 0·01; 95% CI , 0·00–0·02; P = 0·06). Conclusions Dysglycaemia is associated with reduced bone mass accrual in youth with CF , in addition to recognized factors such as abnormal lung function, poor nutritional status and disease severity. Bone health assessment is essential in youth with CF .